Wednesday, November 23, 2022: Life Sciences

The Food and Drug Administration (FDA) approved Hemgenix, an IV treatment for adults with hemophilia B. Shortly after the approval, Drugmaker CSL Behring announced that the drug costs $3.5 million a dose, making it the most expensive medicine in the world. CSL Behring...

Tuesday, November 22, 2022: Providers

According to recent reports, health systems nationwide have seen a significant rise in denied claims over the past year. A Kaufman Hall report found that approximately 67 percent of health care leaders reported an increase in claim denials over the past year, compared...